Certain hormonal and nonhormonal binding systems such as the leukoagglutinin-lymphocyte model exhibit complex receptor-ligand interactions that result in nonlinear Scatchard plots. Such plots are interpreted as indicating either homogeneous negatively interacting binding sites or heterogeneous sites with different and fixed affinity. We assessed the validity of these interpretations in our system by conjugating the ligand to a photoactivated heterobifunctional agent and cross-linking the conjugate to a subset of receptors before studying the binding interactions of non-cross-linked sites. Conjugation did not qualitatively or quantitatively affect the binding properties of the ligand. Crosslinking was specific, efficient, and stable and had no effect on irrelevant surface receptors. Cross-linking of only 3% of the total receptors resulted in 50% decreased ligand binding to high affinity sites consistent with a calculated inactivation of 85% and 2% of high and low affinity sites, respectively. Such preferential inactivation of high affinity sites is an unequivocal demonstration of binding site heterogeneity in this system and shows a clear rejection of the homogeneous cooperation model.
Introduction
Evidence suggests that complex receptor-ligand interactions in certain hormonal and nonhormonal systems reflect occupancydependent affinity (1, 2) . To date, such evidence has relied on demonstrating enhanced dissociation of bound labeled ligand as receptor occupancy is increased by addition of an excess of unlabeled ligand to the dissociation mixture (1, 2) . While suggestive, this approach fails to prove the existence of negatively interacting binding sites (3) (4) (5) (6) (7) . Thus, the existence of heterogeneous binding sites with different but fixed affinity for the ligand remains the preferred explanation of such complex binding interactions. Objective resolution ofthe uncertainty regarding binding models underlying complex binding interactions is hampered by the phenomenological nature of receptor-ligand binding studies and by methodological limitations that preclude selectively studying each class of heterogeneous binding sites. If receptors belonging to one oftwo distinct classes ofbinding sites were cross-linked to the ligand, then data from post-cross-linking binding studies would reflect the second non-cross-linked class of receptor. Such an approach might provide an experimental ligand system that generates binding data compatible with either homogeneous interacting or with heterogeneous binding sites with different and fixed affinities, we have examined the binding interactions of one of the two assumed receptor classes after selectively cross-linking the other receptor class with a photoactivated heterobifunctional reagent. Our observations clearly show that in the LPHA-lymphocyte system, complex binding interactions reflect binding site heterogeneity and are inconsistent with the negatively cooperative model.
Methods

Cells
IM9, a B-lymphoblastoid cell line, was grown in RPMI 1640 (Gibco, Grand Island, NY) with 10% fetal calf serum (MA Bioproducts, Walkersville, MD) at 37°C in a 5% CO2 incubator (Forma Scientific, Marietta, OH). Before binding assays, cells were harvested by centrifugation at 200 g for 10 min and washed three times with medium. Cell viability assessed by Trypan Blue dye exclusion was consistently >95%.
PHA purification and iodination LPHA, a potent mitogenic lectin (8, 9) , was prepared from a single batch of PHA-P (Difco Laboratories, Inc., Detroit, MI) according to a modification of the column chromatography methods of Weber (8) , as previously described (9) . LPHA was iodinated (with reductant-free '25I or 1'3I, 17 and 20 Ci/mg sp act, respectively, Amersham Corp., Arlington Heights, IL) by the chloramine-T method of Hunter and Greenwood (10) to a specific activity of0.1-1 Ci/Ag. Details ofthe LPHA purification and iodination procedures, and of its biological activity have been published elsewhere (9, 11, 12) . ibrated with 0.15 M phosphate buffer, pH 7.4. The pooled radioactive peak containing the activated radiolabeled lectin ('25I-LPHA-ANB-AI, 0.1-1 Ci/;g sp act) was in aliquots and stored at -70°C. All manipulations of the activated lectin were carried out in the dark.
Receptor-ligand binding studies Binding equilibrium. Increasing concentrations (1.5 x 10' M to 1.5 X 10-6 M) of 13 I-LPHA ofconstant specific activity were incubated with fresh cells (106 aliquots) or with cell aliquots previously cross-linked with tracer concentrations (2.65 X 10-8 M) of 125I-LPHA-ANB-AI in 0.5 ml Hanks' buffer containing 0.1% of bovine serum albumin (BSA; Sigma Chemical Co., St. Louis, MO) in polystyrene tubes precoated overnight with 0.5% BSA in Hanks' buffer to minimize nonspecific binding. Controls included '3'I-LPHA binding to fresh cells in the presence of equimolar concentrations of ANB-AI and equilibrium binding ofequimolar concentrations of 125I-LPHA-ANB-AI ofconstant specific activity to fresh cells. After reaching equilibrium (60 min incubation at 22°C) the bound and unbound tracer from each incubation were separated by centrifugation over a 4:1 mixture of dibutyl phthalate and bis-2-ethylhexyl phthalate (Eastman Kodak Co., Rochester, NY) at 10,000 g (Microfuge 12; Beckman Instruments, Inc., Fullerton, CA) for 2 min in conical microcentrifuge tubes (Sarstedt, Inc., Princeton, NJ). The centrifuge tube tips containing the cell pellet were cut off and cell-bound radioactivity of the pellet was determined in a gamma counter (Gamma 4000; Beckman Instruments, Inc.). Aliquots of cells cross-linked with '25I-LPHA-ANB-AI but not exposed to '3'1-LPHA were counted to determine the amount and efficiency of cross-linking. In some experiments binding of 1251-insulin to IM-9 cells under steady state was determined as described for LPHA except that cells were incubated with 1251-insulin (1.7 X 10-" M) in the presence of increasing concentrations of native insulin.
Dissociation studies. Cells (106 aliquots) were exposed to tracer amounts (2.65 x 10-8 M) of '251-LPHA or 125I-LPHA-ANB-AI in 0.1 ml of Hanks' buffer containing 0.1% BSA (Hanks'-BSA). After reaching equilibrium, cells were irradiated and unbound tracer ligand was removed by washing the cells twice with Hanks'-BSA buffer at 4°C and replacing the supernatant with 50 volumes ofHanks'-BSA buffer alone or in buffer containing native LPHA in concentrations equal to the '251-LPHA present in the original sample. Volume dilution prevents reassociation of ligand released during the dissociation reaction (1, 2) . Addition ofnative LPHA increases the overall occupancy by the ligand and thus enhances tracer dissociation, as described for this (2) and other systems ( 14) . At various times, duplicate cell aliquots were processed as described above to ascertain receptor ligand complex dissociation.
Receptor-LPHA cross-linking
Cross-linking was induced as follows: After equilibration with tracer concentrations of 1251I-LPHA-ANB-AI, cells were placed in a BSA-precoated quartz glass tube and irradiated for 5 min. Irradiations were carried out in a Rayonet photochemical reactor (RMR-500; Southern New England Ultraviolet Co., Hamden, CT). The apparatus contains four fluorescent tubes with an output of 975 milliwatts each at 300 nm arranged around a cylinder. This long wavelength light increases the reactivity of the photo-generated arylnitrene and reduces undesirable photolysis on other amino acid residues of the conjugated protein (15) . The samples in glass tubes rotate at 5 rpm in a carousel (Merry-go-round, RMR-400; Southern New England Ultraviolet Co., Hamden, CT), insuring uniform irradiation of all samples.
Data analysis
Specific LPHA and insulin binding was calculated from total binding by subtracting nonspecific binding, as determined by binding of radioligand in the presence of 1,000-fold excess of native ligand. Data from dual radiolabel experiments were corrected for spilldown of 13'I counts into the 1251I window. Data are presented as averages of replicate experiments as indicated in the figure legends. In all experiments, each data point is assessed in duplicate. Standard deviations (not shown) were generally <5% of the mean. Equilibrium binding data were analyzed by curve-fitting using the least-square "ligand" program (16) ( 17) .
Results
Properties ofthe 125I-LPHA-ANB-AI conjugate. Fig. 1 shows the radioactivity, protein, and ANB-AI profiles of the fractionation eluate ofthe modified '251I-LPHA. As shown, nearly all the modified 125I-LPHA eluted between fractions 11 and 16 with clearcut separation between the conjugated and the unconjugated fractions of ANB-AI. The figure inset shows the absorption spectra of the modified and unmodified LPHA. Based on the extinction coefficient of ANB-AI (E = 9 X I03 M`at 318 nm), the molecular weight of LPHA (128,000), and the contribution of ANB-AI to the modified LPHA absorbance at 318 nM, the molar ratio of reagent to lectin can be estimated. Reaction conditions were chosen to generate conjugates with an ANB-AI to LPHA molar ratio of 1. Because one cross-link is sufficient, such a ratio reduces undesirable cross-linking to nonreceptor surface moieties often associated with excesses of heterobifunctional reagent.
Effect ofANB-AI on LPHA binding. Whether or not ANB-AI affects the magnitude or affinity of LPHA binding to lymphocyte receptors was ascertained in the following experiments. Cells were equilibrated either with 1.5 X 10-9 M to 1.5 X 10-6 M of '3ll-LPHA in the presence and absence of equimolar concentrations of ANB-AI or with 1.5 X 10-9 M to 1.5 Xt 10-6 M '251-LPHA-ANB-AI conjugate as described under Methods. As shown in Fig. 2 A, binding of LPHA to its lymphocyte receptors was substantially the same at all ligand concentrations in each set of experiments. Replots in Scatchard coordinates (Fig. 2 B) show that binding data from each set of experiments generates a virtually identical curvilinear Scatchard plot. Thus, under these experimental conditions, ANB-AI does not affect the magnitude or complexity of LPHA binding either as unconjugated reagent in the reaction mixture or when conjugated to the binding ligand. (1, 14) . As shown in Fig. 3 (Fig. 3 B) This report shows that a select fraction of LPHA receptors can be cross-linked to LPHA by the heterobifunctional agent ANBAl and that selective binding interaction studies can be conducted on the non-cross-linked receptor population. One attractive feature of the heterobifunctional agent ANB-AI is that it can be activated with 300 nm ultraviolet light (13) reducing to a minimum radiation damage to the target (13, 18) . This is ofparticular importance when intact cells are involved. Crucial to the interpretation of our results, and the validity of our conclusions, is the assessment of the specificity and efficiency of cross-linking; the distinction between cross-linked and non-cross-linked receptors; and the evaluation of the possible contribution of biological cross-linking during photolysis (19, 20) . analysis of the Scatchard plot indicates that cross-linking inactivation of 3% of the total receptors eliminates 85% of the low capacity-high affinity receptors but only 2% ofthe high capacitylow affinity sites (Fig. 3 B) , which is consistent with a two-class heterogeneous binding site interpretation (Fig. 4) . It could be argued that the receptor-LPHA-ANB-AI complex dissociates but that the conjugate remains cross-linked by the ANB-AI at a site other than the LPHA receptor. Should this be the case, crosslinking would have no effect on binding interactions because, in effect, all receptors would remain available to the unconjugated tracer ligand. However, two conditions must be met for this to occur: (a) cross-linking would have to be random rather than receptor-specific, and (b) the association constant of the unconjugated ligand should be greater than the dissociation rate ofthe conjugated ligand (concerted substitution hypothesis). However, such alternative explanation of our data is inconsistent with our findings that cross-linking is receptor-specific and that conjugation did not measurably affect the dissociation constant for the ligand. We did not examine and therefore cannot extrapolate our conclusions to other systems with complex binding interactions. However, given the striking similarities in equilibrium and kinetic binding data derived from LPHA and certain other ligands (2, 4, 9, 14) , it is unlikely that our observations represent a phenomenon restricted to LPHA receptors.
